Researchers from the University of Liège in Belgium reviewed 25 years of research and concluded, “Compelling evidence exists that glucosamine sulfate may reduce the progression of knee osteoarthritis.”
The Zoft Gum Company, which makes several herbal supplement chewing gums (eg, breast enlargement, weight reduction) has introduced a new gum to help manage the symptoms of menopause.
There are no studies of this gum for treating menopausal symptoms in women. And the discussion of the gum’s ingredients on the Zoft website is misleading.
Here is an update to the Cochrane Review of echinacea summarized here in July.
Their consensus was that taking echinacea after the onset might shorten the cold, but does not prevent the onset of the common cold. Even at this, the experts were skeptical.
Now another analysis of clinical trials has come to a different conclusion.
Research reported during the latest meeting of the American Society for Pharmacology and Experimental Therapeutics concludes that these herbals do not place people at risk for certain types of drug interactions.
It’s especially important considering that these product routinely have poor quality control and mislabeling problems, as noted here, here, here, and here.
Companies must stop manufacturing and distributing trimethobenzamide hydrochloride (Tigan, Tebamide, T-Gen, Trimazide, and Trimethobenz) suppositories.